搜尋結果
Sabadell shares rise further on BBVA merger proposal, but well below premium
Reuters· 27 分鐘前, opens new tab announced a merger proposal this week, but still far off the premium offered as the market assessed the ...
Have a high-risk home? Here's how to get homeowners insurance
CNBC· 35 分鐘前Home insurance companies determine coverage based on the risk of a claim being filed, the type ...
US FDA approves Neurocrine Biosciences' movement disorder drug (April 30)
Reuters· 54 分鐘前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 60 分鐘前Moderna on Thursday posted a narrower-than-expected loss for the first quarter as the ...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters· 1 小時前Sales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the ...
In Jamie Dimon's America, the Stock Market Has Already Voted
Bloomberg· 3 小時前Investors around the world value US equities more highly than ever before in what John Maynard ...
瞄準 24 億美元商機!祥翊與 S 公司簽署肺纖維化藥物美國銷售合約
科技新報 TechNews· 3 小時前祥翊製藥今日宣布旗下治療肺纖維化藥物 NTN 與 S 公司簽訂美國市場銷售合約,未來將由祥翊進行生產製 ...
Scammers flood US class action settlements with fraudulent claims
Reuters· 3 小時前Artsana, a maker of child car booster seats, last year agreed to settle claims that it had misled customers about how to ...
Carbon credit standards approval extended to 98% of market
Reuters· 4 小時前Five of the world's largest carbon credit programmes have now been given initial approval by a body tasked ...
Shrunken Vodafone has narrow path to growth
Reuters· 6 小時前The CEO of the British telecom operator has agreed to sell the group’s stuttering Spanish and ...